BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 19, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Feb. 25, 2025

Feb. 25, 2025
Med-tech firms raising money in public or private financings, including: Bioaffinity, Cercare, Precision Optics, Predictmedix.
Read More

Financings for Feb. 24, 2025

Feb. 24, 2025
Biopharmas raising money in public or private financings, including: Blue Water Acquisition, Firefly Neuroscience.
Read More
~

Berlin Heals raises funds for device to reverse heart failure

Feb. 24, 2025
By Shani Alexander
Berlin Heals Holding AG recently raised over CHF7 million (US$7.8 million) in a financing round for C-MIC, a small implantable device it believes can reverse heart failure.
Read More

Financings for Feb. 24, 2025

Feb. 24, 2025
Med-tech firms raising money in public or private financings, including: Boston Scientific, Firefly Neuroscience Inc., Organox, Pavmed, Sonar, Veris Health.
Read More

Financings for Feb. 21, 2025

Feb. 21, 2025
Biopharmas raising money in public or private financings, including: Atai.
Read More

Financings for Feb. 21, 2025

Feb. 21, 2025
Med-tech firms raising money in public or private financings, including: Allurion, Cagent Vascular, Intelligent Bio, Precision Optics.
Read More
3D Euro symbol

EG 427 adds €27M series B for neurogenic bladder program

Feb. 20, 2025
By Nuala Moran
EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical trial of the lead gene therapy program, opening the way for its herpes simplex viral-vectored products to be developed in a range of chronic neuro-urology disorders.
Read More

Financings for Feb. 20, 2025

Feb. 20, 2025
Biopharmas raising money in public or private financings, including: Allurion, Maia, Reverb.
Read More

Financings for Feb. 20, 2025

Feb. 20, 2025
Med-tech firms raising money in public or private financings, including: Anbio Biotechnology Ltd., Approxima Srl, Atrandi Biosciences, Level Zero Health., Valencia Technologies, Vitalconnect Inc.
Read More

Financings for Feb. 19, 2025

Feb. 19, 2025
Biopharmas raising money in public or private financings, including: Bambusa, Perceive, Plus.
Read More
Previous 1 2 … 95 96 97 98 99 100 101 102 103 … 653 654 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing